Insights On Pharmaceutical Packaging
-
The Rising Need For Flexibility In Blister Packaging For CDMOs And Drug Manufacturers
8/1/2024
In the pharmaceutical industry, processes are subject to continuous change due to evolving requirements and regulations. Consequently, pharmaceutical companies and contract packagers often require adaptable packaging solutions, such as blister machines, to meet these dynamic needs.
-
Establishing And Safeguarding Shelf Life In Combination Products
10/27/2025
Establishing combination product shelf life requires aligning stability. Holistic, data-driven stability studies ensure product function, safety, and label claims through the entire supply chain.
-
3D Screen Printing: Enabling A New Generation Of Complex Formulations
3/17/2025
Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.
-
Characterizing The E&L Profile Of Stoppers For Drug Stability
6/11/2024
The significance of E&L testing lies in its ability to identify potential risks associated with the use of containers and packaging materials in the pharmaceutical industry.
-
Stick-Pack Benefits For Pharmaceuticals And Nutraceuticals
10/24/2024
Explore the key advantages of stick-pack formats for pharmaceuticals and nutraceuticals, from enhanced product safety and cost-efficiency to improved compliance and marketability.
-
The Enhanced Version Of Ready-To-Use Vial Platform
1/13/2025
Discover a platform for aseptic manufacturing that offers pre-sterilized vials for biologics to improve efficiency and safety with automated filling systems and advanced packaging for optimized drug containment.
-
Step Into The Future Of ATMP Fill-Finish
5/21/2025
Discover the future of ATMP manufacturing as Josh Russell from AST demonstrates an advanced, fully automated fill-finish system featuring automated bag and tub opening, as well as the Atmos isolator.
-
Find Flexibility And Scalability With Modular Assembly Equipment
9/30/2025
Find tailor-made solutions designed to deliver high-quality standards even when scaling up. Modularity enhances production efficiency, saves costs, and shortens time to market.
-
De-Risking The Transition From Vial To Drug-Device Combination Product
7/25/2025
When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.
-
Meeting Annex 1: A Proactive Approach To Regulatory Compliance
3/4/2025
It was imperative for a large European CMO that produces multiple biologic drugs to select the right product quality and value for each customer to comply with the August 2023 revision to the EU GMP Annex 1.